Understanding the Placebo Effect in FGIDs
The Clinical Trial Environment is the Key Driver - Not the Deception of the Placebo Pill
- Randomization after run-in ensures robust baseline for drug evaluation
- Enrichment and patient-centric design aligns with FDA Guidelines
